BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19645436)

  • 1. Novel regulation of Smad3 oligomerization and DNA binding by its linker domain.
    Vasilaki E; Siderakis M; Papakosta P; Skourti-Stathaki K; Mavridou S; Kardassis D
    Biochemistry; 2009 Sep; 48(35):8366-78. PubMed ID: 19645436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
    Prokova V; Mavridou S; Papakosta P; Petratos K; Kardassis D
    Biochemistry; 2007 Dec; 46(48):13775-86. PubMed ID: 17994767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.
    Makkar P; Metpally RP; Sangadala S; Reddy BV
    J Mol Graph Model; 2009 Apr; 27(7):803-12. PubMed ID: 19157940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel transcriptionally active domain in the transforming growth factor beta-regulated Smad3 protein.
    Prokova V; Mavridou S; Papakosta P; Kardassis D
    Nucleic Acids Res; 2005; 33(12):3708-21. PubMed ID: 15994459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
    Imoto S; Sugiyama K; Sekine Y; Matsuda T
    FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
    Warner DR; Greene RM; Pisano MM
    FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dominant negative Smad antagonists to TGFbeta signaling.
    Ho J; Chen H; Lebrun JJ
    Cell Signal; 2007 Jul; 19(7):1565-74. PubMed ID: 17360157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echinococcus multilocularis: molecular characterization of EmSmadE, a novel BR-Smad involved in TGF-β and BMP signaling.
    Epping K; Brehm K
    Exp Parasitol; 2011 Oct; 129(2):85-94. PubMed ID: 21802416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
    Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
    Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins.
    Oka C; Tsujimoto R; Kajikawa M; Koshiba-Takeuchi K; Ina J; Yano M; Tsuchiya A; Ueta Y; Soma A; Kanda H; Matsumoto M; Kawaichi M
    Development; 2004 Mar; 131(5):1041-53. PubMed ID: 14973287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of a second structurally unusual AR-Smad without an MH1 domain and a Smad4 orthologue from Echinococcus multilocularis.
    Zavala-Góngora R; Derrer B; Gelmedin V; Knaus P; Brehm K
    Int J Parasitol; 2008 Feb; 38(2):161-76. PubMed ID: 17845804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases.
    Vardouli L; Vasilaki E; Papadimitriou E; Kardassis D; Stournaras C
    FEBS J; 2008 Aug; 275(16):4074-87. PubMed ID: 18631173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation.
    Izzi L; Attisano L
    Oncogene; 2004 Mar; 23(11):2071-8. PubMed ID: 15021894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation.
    Azmi P; Seth A
    Eur J Cancer; 2005 Nov; 41(16):2549-60. PubMed ID: 16226459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and expression of HySmad1, a member of the R-Smad family of TGFbeta signal transducers, in the diploblastic metazoan Hydra.
    Hobmayer B; Rentzsch F; Holstein TW
    Dev Genes Evol; 2001 Dec; 211(12):597-602. PubMed ID: 11819117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
    Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
    J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phosphatase controls the fate of receptor-regulated Smads.
    Schilling SH; Datto MB; Wang XF
    Cell; 2006 Jun; 125(5):838-40. PubMed ID: 16751094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of nuclear export of Smad3 involves exportin 4 and Ran.
    Kurisaki A; Kurisaki K; Kowanetz M; Sugino H; Yoneda Y; Heldin CH; Moustakas A
    Mol Cell Biol; 2006 Feb; 26(4):1318-32. PubMed ID: 16449645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.